Annual report pursuant to Section 13 and 15(d)

Public Offering (Details)

v3.21.1
Public Offering (Details)
12 Months Ended
Oct. 14, 2020
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Aug. 24, 2020
$ / shares
Subsidiary or Equity Method Investee [Line Items]      
Number of units issued | shares | shares   50,000,000  
Number Of Business Days   15 days  
Warrant exercise price   $ 11.50  
Warrant exercisable term, after the completion of the Business Combination   30 days  
Warrant exercisable term, from the closing of the public offering   12 months  
Warrant expiration term   24 months  
Warrants redemption description   the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days' prior written notice of redemption to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 value per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.  
Warrant Redemption period   30 days  
Underwriting discount | $   $ 27,500,000  
Class A common stock      
Subsidiary or Equity Method Investee [Line Items]      
Common stock par value (in dollars per share)   $ 0.0001 $ 0.0001
Closing share price   $ 18.00  
Public Offering      
Subsidiary or Equity Method Investee [Line Items]      
Number of units issued | shares | shares 50,000,000 50,000,000  
Price per unit $ 10.00    
Warrant Convertible Ratio 0.33    
Closing share price   $ 10.00  
Underwriting discount | $ $ 10,000,000    
Underwriting discount per unit 0.20    
Additional fee deferred discount | $ $ 17,500,000    
Additional fee deferred discount per unit 0.35